Learn how to identify & combat age-based discrimination for improved communication & better patient outcomes.
New Guidance on Mental Health Screening in Pediatric Rheumatology
Pediatric rheumatologic diseases are characterized by high rates of anxiety & depression known to impact health-related outcomes. CARRA and the ACR developed guidance statements to assess & manage mental health concerns for youths in pediatric rheumatology practice.
ACR Award Shines Light on Community Rheumatology Practice Innovation
The 2026 Community Practice Innovation Award supports projects that enhance care delivery, improve outcomes and address real-world challenges in rheumatology.
New Patient- & Provider-Focused Resources Focus on Improving Lupus Care
With resources and programs running online and on the ground in 47 states, COIN’s projects are having a massive impact on the field of rheumatology.
Rheumatologists Applaud Inclusion of Key Medications in Medicare Price Talks
In a powerful op-ed published by Fierce Healthcare, rheumatologists Amanda Myers, MD, and Rebecca Shepherd, MD, MBA—both volunteer advocates with the ACR—highlighted the critical role of the Centers for Medicare & Medicaid Services (CMS) in improving access to life-changing medications for patients with autoimmune and rheumatic diseases. Many patients with chronic conditions, such as rheumatoid…
New H-1B Visa Fee Sparks Concern Over Physician Shortages, Access to Care
If physicians and other healthcare workers are not exempted from the $100,000 fee, the rheumatology workforce may be negatively affected, possibly increasing pressure on existing providers and extending patient wait times.
Rheumatology Research Foundation Launches $1 Million Emergency Fund to Safeguard Innovation
In the wake of unprecedented federal research cuts, the new $1 million emergency funding commitment aims to protect vital projects and the future of patient care.
Advocacy Opportunities Abound at ACR Convergence
At ACR Convergence 2025, the ACR advocacy team will be hosting a slate of programming to help you understand the power of advocacy and prepare you to add your voice in support of the rheumatology community.
ACR Leads Sign-on Letter to Cigna Opposing Downcoding of E/M Claims
The ACR recently led a rheumatology community letter to Cigna opposing the payer’s decision to downcode level 4 and 5 evaluation and management claims.
Benefits of Early Initiation of Biologic DMARDs in pJIA
The early initiation of biologic disease-modifying anti-rheumatic drugs (DMARDs) may reduce the overall disease burden in patients with polyarticular juvenile idiopathic arthritis (pJIA), according to findings from Ringold et al.
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 834
- Next Page »